These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 688724)

  • 21. Gestational age and indomethacin elimination in the neonate.
    Evans MA; Bhat R; Vidyasagar D; Vadapalli M; Fisher E; Hastreiter A
    Clin Pharmacol Ther; 1979 Dec; 26(6):746-51. PubMed ID: 498716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Investigation of Metabolic and Renal Clearance Pathways Contributing to the Elimination of Fevipiprant Using Probenecid as Perpetrator.
    Weiss HM; Langenickel T; Cain M; Kulkarni S; Shah B; Vemula J; Rahmanzadeh G; Poller B
    Drug Metab Dispos; 2021 May; 49(5):389-394. PubMed ID: 33632715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of probenecid on the elimination and protein binding of ceftriaxone.
    Stoeckel K; Trueb V; Dubach UC; McNamara PJ
    Eur J Clin Pharmacol; 1988; 34(2):151-6. PubMed ID: 3383987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of furosemide's diuretic effect by indomethacin: pharmacokinetic evaluation.
    Smith DE; Brater DC; Lin ET; Benet LZ
    J Pharmacokinet Biopharm; 1979 Jun; 7(3):265-74. PubMed ID: 480148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J; Blair AD; Cutler RE
    Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):53-62. PubMed ID: 8061834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osmosin: its effect on plasma and synovial fluid kinetics of indomethacin.
    Fowler PD; Dawes PT
    Eur J Clin Pharmacol; 1985; 27(6):689-91. PubMed ID: 3987775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of probenecid on the formation and elimination kinetics of the sulphate and glucuronide conjugates of diflunisal.
    Macdonald JI; Wallace SM; Herman RJ; Verbeeck RK
    Eur J Clin Pharmacol; 1995; 47(6):519-23. PubMed ID: 7768255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of probenecid on the kinetics of epsilon-aminocaproic acid.
    Dvorchik BH; Katlic KL; Hayes AH; Eyster ME
    Clin Pharmacol Ther; 1980 Aug; 28(2):223-8. PubMed ID: 7398189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Capacity-limited renal glucuronidation of probenecid by humans. A pilot Vmax-finding study.
    Vree TB; Van Ewijk-Beneken Kolmer EW; Wuis EW; Hekster YA
    Pharm Weekbl Sci; 1992 Oct; 14(5):325-31. PubMed ID: 1437517
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Competitive inhibition of zidovudine clearance by probenecid during continuous coadministration.
    Wong SL; Hedaya MA; Sawchuk RJ
    Pharm Res; 1992 Feb; 9(2):228-35. PubMed ID: 1553347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacokinetics of probenecid.
    Cunningham RF; Israili ZH; Dayton PG
    Clin Pharmacokinet; 1981; 6(2):135-51. PubMed ID: 7011657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Saturable kinetics of intravenous chlorothiazide in the rhesus monkey.
    Gustafson JH; Benet LZ
    J Pharmacokinet Biopharm; 1981 Aug; 9(4):461-76. PubMed ID: 7310644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent kinetics of probenecid in rhesus monkeys--infusion studies.
    Chiang CW; Benet LZ
    Pharmacology; 1984; 28(4):181-7. PubMed ID: 6728896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of probenecid following oral doses to human volunteers.
    Selen A; Amidon GL; Welling PG
    J Pharm Sci; 1982 Nov; 71(11):1238-42. PubMed ID: 7175716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of indomethacin.
    Alván G; Orme M; Bertilsson L; Ekstrand R; Palmér L
    Clin Pharmacol Ther; 1975 Sep; 18(3):364-73. PubMed ID: 1100305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A clinical and pharmacokinetic study of indomethacin in standard and slow release formulations.
    Adams KR; Halliday LD; Sibeon RG; Baber N; Littler T; Orme ML
    Br J Clin Pharmacol; 1982 Aug; 14(2):286-9. PubMed ID: 7104182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares.
    Donecker JM; Sams RA; Ashcraft SM
    Am J Vet Res; 1986 Jan; 47(1):89-95. PubMed ID: 3946913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibitory effect of probenecid on renal excretion of famotidine in young, healthy volunteers.
    Inotsume N; Nishimura M; Nakano M; Fujiyama S; Sato T
    J Clin Pharmacol; 1990 Jan; 30(1):50-6. PubMed ID: 2303581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapid high-performance liquid chromatographic assay for the simultaneous determination of probenecid and its glucuronide in urine. Irreversible binding of probenecid to serum albumin.
    Hansen-Møller J; Schmit U
    J Pharm Biomed Anal; 1991; 9(1):65-73. PubMed ID: 2043725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.